Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tarceva phase III trial in pancreatic cancer achieves target enrollment

Jan. 30, 2003

Triapine enters further phase II trial in prostate cancer

Jan. 29, 2003

Onyx discontinues development of ONYX-015 to focus on Bay-43-9006

Jan. 29, 2003

New data on once-daily lonafarnib in patients with advanced solid tumors

Jan. 28, 2003

Lilly claims antitumor benzoylsulfonamides and sulfonylbenzamidines

Jan. 28, 2003

rHu-KGF reduces severe oral mucositis in bone marrow transplant patients

Jan. 27, 2003

Antiinflammatory effects of omega-3 fatty acids

Jan. 24, 2003

Velcade NDA submitted for multiple myeloma

Jan. 24, 2003

Yamanouchi reports novel VEGF inhibitors

Jan. 24, 2003

RK-0202 enters phase II evaluation in oral mucositis

Jan. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...